|
70 Companies |
|
97 Products |
|
97 Products |
|
124 Mechanisms of Action |
|
1 Trial |
|
1962 News |
|
| «12...4567891011121314...3940» |
- ||||||| hydromorphone hydrochloride / Generic mfg.
Trial completion: Study to Assess Longer-term Opioid Medication Effectiveness (SALOME) (clinicaltrials.gov) - Jun 10, 2016
P3, N=202, Completed, Sponsor: University of British Columbia
Active, not recruiting --> Completed
- Trial completion: VIGICANN: Study of the Relationship Between Dose-concentration-effect of Delta-9-tetrahydrocannabinol (THC) and the Ability to Drive in Chronic or Occasional Cannabis Users (clinicaltrials.gov) - Jun 10, 2016
P=N/A, N=37, Completed, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial primary completion date, HEOR: AdolCHICA: Improving Adolescent Health Outcomes Through Preventive Care Transformation (clinicaltrials.gov) - May 27, 2016
P2, N=2831, Recruiting, Sponsor: Indiana University
Active, not recruiting --> Completed Trial primary completion date: Oct 2015 --> Oct 2016
- Enrollment open: OTS ETOH-3: Oxytocin Treatment of Alcohol Dependence (clinicaltrials.gov) - May 27, 2016
P2, N=50, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Oct 2015 --> Oct 2016 Not yet recruiting --> Recruiting
- aspirin / Generic mfg.
Enrollment closed: Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers (clinicaltrials.gov) - May 23, 2016
P2, N=56, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Vivitrol (naltrexone extended-release injectable suspension) / Alkermes
Trial completion: Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence (clinicaltrials.gov) - May 18, 2016
P1/2, N=12, Completed, Sponsor: New York State Psychiatric Institute
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial primary completion date: Adaptive Treatment for Adolescent Cannabis Use Disorders (clinicaltrials.gov) - May 13, 2016
P=N/A, N=172, Active, not recruiting, Sponsor: University of Connecticut Health Center
Recruiting --> Completed Trial primary completion date: Feb 2016 --> Jul 2016
- lorazepam / Generic mfg.
Trial withdrawal: GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1 (clinicaltrials.gov) - May 13, 2016
P1/2, N=0, Withdrawn, Sponsor: University of California, Los Angeles
Trial primary completion date: Feb 2016 --> Jul 2016 Terminated --> Withdrawn
- Enrollment closed, Enrollment change: Delivery of Anxiety Disorder Treatment in Addictions Centers (clinicaltrials.gov) - May 13, 2016
P=N/A, N=98, Active, not recruiting, Sponsor: University of California, Los Angeles
Terminated --> Withdrawn Recruiting --> Active, not recruiting | N=80 --> 98
- Trial completion: Way to Quit - Comparative Efficacy, Acceptance and Effectiveness of Health Incentive Structures (clinicaltrials.gov) - May 13, 2016
P=N/A, N=2185, Completed, Sponsor: University of Pennsylvania
Recruiting --> Active, not recruiting | N=80 --> 98 Active, not recruiting --> Completed
- Enrollment closed, Enrollment change, Trial primary completion date: Tailored Mobile Text Messaging to Reduce Problem Drinking (clinicaltrials.gov) - May 12, 2016
P=N/A, N=174, Active, not recruiting, Sponsor: Northwell Health
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=300 --> 174 | Trial primary completion date: Jul 2015 --> Dec 2015
- Trial primary completion date: Project Relay Model for Recruiting Alcohol Dependent Patients in General Hospitals (clinicaltrials.gov) - May 11, 2016
P=N/A, N=1000, Recruiting, Sponsor: University of Southern Denmark
Recruiting --> Active, not recruiting | N=300 --> 174 | Trial primary completion date: Jul 2015 --> Dec 2015 Trial primary completion date: Feb 2016 --> Jun 2017
- Campral EC (acamprosate delayed release) / EMD Serono, Nippon Shinyaku
Trial termination: Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees (clinicaltrials.gov) - May 11, 2016
P4, N=26, Terminated, Sponsor: Virginia Commonwealth University
Trial primary completion date: Feb 2016 --> Jun 2017 Completed --> Terminated; Not enough sugjects enrolled before funding ran out
- Trial completion, Trial primary completion date: Phendimetrazine and Cocaine (clinicaltrials.gov) - May 11, 2016
P0, N=10, Completed, Sponsor: University of Kentucky
Completed --> Terminated; Not enough sugjects enrolled before funding ran out Recruiting --> Completed | Trial primary completion date: May 2016 --> Dec 2015
- Trial primary completion date: Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress (clinicaltrials.gov) - May 4, 2016
P1, N=66, Recruiting, Sponsor: Medical University of South Carolina
Recruiting --> Completed | Trial primary completion date: May 2016 --> Dec 2015 Trial primary completion date: Jan 2016 --> Jan 2017
- naltrexone / Generic mfg.
Trial completion: Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism (clinicaltrials.gov) - May 4, 2016
P4, N=152, Completed, Sponsor: Medical University of South Carolina
Trial primary completion date: Jan 2016 --> Jan 2017 Active, not recruiting --> Completed
- Trial primary completion date: Effect of Anti-craving Medication on Cognitive Functions in Alcohol Dependence: an ERP Study (clinicaltrials.gov) - May 3, 2016
P=N/A, N=80, Recruiting, Sponsor: Brugmann University Hospital
Active, not recruiting --> Completed Trial primary completion date: Dec 2016 --> Jun 2017
- Trial completion: Individual vs. Group Community Reinforcement Training to Help Parents of Substance-using Treatment-refusing Youth (clinicaltrials.gov) - May 3, 2016
P=N/A, N=60, Completed, Sponsor: Oregon Research Institute
Trial primary completion date: Dec 2016 --> Jun 2017 Active, not recruiting --> Completed
- Trial completion, Enrollment change: StPaulKorea: Team-based Financial Incentives for Smoking Cessation (clinicaltrials.gov) - May 3, 2016
P=N/A, N=28, Completed, Sponsor: St.Paul's Hospital, Korea
Active, not recruiting --> Completed Recruiting --> Completed | N=60 --> 28
- ||| methadone / Generic mfg.
Trial completion: METODO: Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT. (clinicaltrials.gov) - Apr 28, 2016
P=N/A, N=500, Completed, Sponsor: L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Recruiting --> Completed | N=60 --> 28 Active, not recruiting --> Completed
- Trial primary completion date, HEOR: Medical Marijuana Use in HIV+ Patients Prospective Cohort Study (clinicaltrials.gov) - Apr 27, 2016
P=N/A, N=150, Active, not recruiting, Sponsor: Wayne State University
Active, not recruiting --> Completed Trial primary completion date: May 2016 --> Sep 2016
- Trial completion, Enrollment change: Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho (clinicaltrials.gov) - Apr 21, 2016
P=N/A, N=1754, Completed, Sponsor: Swiss Tropical & Public Health Institute
Trial primary completion date: May 2016 --> Sep 2016 Active, not recruiting --> Completed | N=1000 --> 1754
- Enrollment closed, Trial primary completion date: Integrated Collaborative Care for Substance Use Disorders (clinicaltrials.gov) - Apr 19, 2016
P=N/A, N=397, Active, not recruiting, Sponsor: RAND
Active, not recruiting --> Completed | N=1000 --> 1754 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Jul 2016
- Arcalyst (rilonacept) / Regeneron, Kiniksa
Trial completion, Enrollment change, Trial primary completion date: A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis (clinicaltrials.gov) - Apr 19, 2016
P2, N=5, Completed, Sponsor: Timothy Morgan, MD
Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Jul 2016 Not yet recruiting --> Completed | N=186 --> 5 | Trial primary completion date: Sep 2018 --> Apr 2016
- isradipine / Generic mfg.
Trial completion, Enrollment change: Improving Buprenorphine Detoxification Outcomes With Isradipine (clinicaltrials.gov) - Apr 19, 2016
P1/2, N=28, Completed, Sponsor: University of Arkansas
Not yet recruiting --> Completed | N=186 --> 5 | Trial primary completion date: Sep 2018 --> Apr 2016 Recruiting --> Completed | N=60 --> 28
- Enrollment closed: RESPECT-PLUS: Services for Infants With Prenatal Opiate Exposure (clinicaltrials.gov) - Apr 15, 2016
P=N/A, N=200, Active, not recruiting, Sponsor: Boston Medical Center
Recruiting --> Completed | N=60 --> 28 Recruiting --> Active, not recruiting
- Trial completion, Compliance: MAPIT: Motivational Assessment Program to Initiate Treatment (clinicaltrials.gov) - Apr 14, 2016
P=N/A, N=380, Completed, Sponsor: University of North Texas Health Science Center
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||| Vivitrol (naltrexone extended-release injectable suspension) / Alkermes
Trial completion: Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM) (clinicaltrials.gov) - Apr 14, 2016
P2, N=100, Completed, Sponsor: San Francisco Department of Public Health
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Intuniv (guanfacine XR) / Shionogi, Takeda
Enrollment closed, Trial primary completion date: Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence (clinicaltrials.gov) - Apr 12, 2016
P1, N=22, Active, not recruiting, Sponsor: New York State Psychiatric Institute
Active, not recruiting --> Completed Completed --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Apr 2016
- diazepam / Generic mfg.
Trial primary completion date: DIAMA: Impact of a One-month Long Detoxification Diazepam Treatment on Early Alcohol Relapse (clinicaltrials.gov) - Apr 9, 2016
P=N/A, N=164, Recruiting, Sponsor: University Hospital, Lille
Completed --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Apr 2016 Trial primary completion date: Jul 2018 --> Jul 2017
- Trial completion, Phase classification: Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial (clinicaltrials.gov) - Apr 8, 2016
P2/3, N=20, Completed, Sponsor: New York State Psychiatric Institute
Trial primary completion date: Jul 2018 --> Jul 2017 Active, not recruiting --> Completed | Phase classification: PN/A --> P2/3
- Enrollment closed, Enrollment change, Trial primary completion date: SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers (clinicaltrials.gov) - Apr 8, 2016
P=N/A, N=98, Active, not recruiting, Sponsor: Friends Research Institute, Inc.
Active, not recruiting --> Completed | Phase classification: PN/A --> P2/3 Recruiting --> Active, not recruiting | N=2168 --> 98 | Trial primary completion date: Mar 2016 --> Jun 2016
- amphetamine/dextroamphetamine immediate release tablet / Generic mfg., topiramate / Generic mfg.
Trial primary completion date: TACT2: Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence (clinicaltrials.gov) - Apr 7, 2016
P2/3, N=176, Recruiting, Sponsor: New York State Psychiatric Institute
Recruiting --> Active, not recruiting | N=2168 --> 98 | Trial primary completion date: Mar 2016 --> Jun 2016 Trial primary completion date: Jun 2016 --> Feb 2017
- quetiapine / Generic mfg.
Enrollment change: Quetiapine for Bipolar Disorder and Alcohol Dependence (clinicaltrials.gov) - Apr 7, 2016
P4, N=90, Completed, Sponsor: University of Texas Southwestern Medical Center
Trial primary completion date: Jun 2016 --> Feb 2017 N=120 --> 90
- Enrollment closed, Enrollment change, Trial primary completion date: PC: Web Intervention for Concerned Partners to Prevent Service Member Alcohol Abuse Abuse (clinicaltrials.gov) - Apr 7, 2016
P=N/A, N=312, Active, not recruiting, Sponsor: RAND
N=120 --> 90 Recruiting --> Active, not recruiting | N=100 --> 312 | Trial primary completion date: May 2016 --> Oct 2015
- morphine sulphate / Generic mfg.
Trial primary completion date: Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS) (clinicaltrials.gov) - Mar 31, 2016
P2, N=64, Enrolling by invitation, Sponsor: Mednax Center for Research, Education and Quality
Recruiting --> Active, not recruiting | N=100 --> 312 | Trial primary completion date: May 2016 --> Oct 2015 Trial primary completion date: Dec 2015 --> Jun 2017
- Chantix (varenicline) / Pfizer
Trial completion, Trial primary completion date: Treatment of Smoking Among Individuals With PTSD (clinicaltrials.gov) - Mar 31, 2016
P2, N=142, Completed, Sponsor: University of Pennsylvania
Trial primary completion date: Dec 2015 --> Jun 2017 Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Dec 2015
- NN1213 / Novo Nordisk
Trial completion: Maintaining Abstinence in Chronic Cigarette Smokers - 1 (clinicaltrials.gov) - Mar 30, 2016
P2, N=407, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Dec 2015 Active, not recruiting --> Completed
- | Selincro (nalmefene oral) / Lundbeck, Acorda
Trial termination: Study of 18 mg Selincro (clinicaltrials.gov) - Mar 30, 2016
P4, N=378, Terminated, Sponsor: H. Lundbeck A/S
Active, not recruiting --> Completed Completed --> Terminated; The study was terminated due to enrolment challenges
- Trial primary completion date: RAFT: Family Therapy Via Video Teleconference for Substance-Abusing Rural Adolescents (clinicaltrials.gov) - Mar 29, 2016
P=N/A, N=120, Recruiting, Sponsor: Oregon Research Institute
Completed --> Terminated; The study was terminated due to enrolment challenges Trial primary completion date: Nov 2015 --> Nov 2016
- Trial primary completion date: OPAL: "Opiates and PhArmacoLogy" (clinicaltrials.gov) - Mar 25, 2016
P=N/A, N=354, Recruiting, Sponsor: Nantes University Hospital
Trial primary completion date: Nov 2015 --> Nov 2016 Trial primary completion date: Aug 2015 --> Jun 2016
- baclofen / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Preventing Alcohol Withdrawal With Oral Baclofen (clinicaltrials.gov) - Mar 24, 2016
P2, N=17, Terminated, Sponsor: Essentia Health
Trial primary completion date: Aug 2015 --> Jun 2016 N=212 --> 17 | Recruiting --> Terminated | Trial primary completion date: Apr 2016 --> Jun 2015; The enrollment in the study was too limited for meaningful data analysis.
- Enrollment open: Automated Recovery Line for Medication Assisted Treatment (clinicaltrials.gov) - Mar 22, 2016
P1/2, N=60, Recruiting, Sponsor: Yale University
N=212 --> 17 | Recruiting --> Terminated | Trial primary completion date: Apr 2016 --> Jun 2015; The enrollment in the study was too limited for meaningful data analysis. Not yet recruiting --> Recruiting
- Enrollment closed: Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients (clinicaltrials.gov) - Mar 21, 2016
P=N/A, N=109, Active, not recruiting, Sponsor: IrisZorg
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial completion, Enrollment change, Trial primary completion date: Modification of Cognitive Processing Therapy (CPT-C) for PTSD and Alcohol Dependence (clinicaltrials.gov) - Mar 21, 2016
P2/3, N=9, Completed, Sponsor: Yale University
Recruiting --> Active, not recruiting Recruiting --> Completed | N=20 --> 9 | Trial primary completion date: Oct 2016 --> Oct 2014
- Enrollment change: Cognitive Processing Intervention for Trauma, HIV/STI Risks, and Substance Use Among Native Women (clinicaltrials.gov) - Mar 18, 2016
P=N/A, N=100, Recruiting, Sponsor: University of Washington
Recruiting --> Completed | N=20 --> 9 | Trial primary completion date: Oct 2016 --> Oct 2014 N=56 --> 100
- |||| Trial completion, Trial primary completion date: REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient) (clinicaltrials.gov) - Mar 18, 2016
P2, N=72, Completed, Sponsor: Pharmicell Co., Ltd.
N=56 --> 100 Recruiting --> Completed | Trial primary completion date: Sep 2015 --> Mar 2016
- | aripiprazole / Generic mfg.
Trial completion: Aripiprazole Effects on Alcohol Drinking and Craving (clinicaltrials.gov) - Mar 18, 2016
P3, N=99, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Completed | Trial primary completion date: Sep 2015 --> Mar 2016 Recruiting --> Completed
- Trial completion: Cognitive Retraining and Brain Stimulation for Alcohol Use (clinicaltrials.gov) - Mar 16, 2016
P=N/A, N=93, Completed, Sponsor: The Mind Research Network
Recruiting --> Completed Recruiting --> Completed
- Trial initiation date, Trial primary completion date, Adherence: Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence (clinicaltrials.gov) - Mar 16, 2016
P2, N=40, Not yet recruiting, Sponsor: Medical University of South Carolina
Recruiting --> Completed Initiation date: Dec 2015 --> May 2016 | Trial primary completion date: Aug 2016 --> Dec 2016